Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves terminal medical institutions, pharmacies, commodity distribution companies, and company franchise stores companies. Shanghai No. 1 Pharmacy Co.,Ltd. was fo… Read more
Shanghai No1 Pharmacy Co Ltd (600833) - Total Assets
Latest total assets as of June 2025: CN¥2.01 Billion CNY
Based on the latest financial reports, Shanghai No1 Pharmacy Co Ltd (600833) holds total assets worth CN¥2.01 Billion CNY as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Shanghai No1 Pharmacy Co Ltd - Total Assets Trend (1994–2024)
This chart illustrates how Shanghai No1 Pharmacy Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Shanghai No1 Pharmacy Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai No1 Pharmacy Co Ltd's total assets of CN¥2.01 Billion consist of 56.9% current assets and 43.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 22.0% |
| Accounts Receivable | CN¥220.55 Million | 11.1% |
| Inventory | CN¥336.32 Million | 17.0% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥38.93 Million | 2.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (1994–2024)
This chart illustrates how Shanghai No1 Pharmacy Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai No1 Pharmacy Co Ltd's current assets represent 56.9% of total assets in 2024, a decrease from 75.7% in 1994.
- Cash Position: Cash and equivalents constituted 22.0% of total assets in 2024, up from 0.0% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is inventory at 17.0% of total assets.
Shanghai No1 Pharmacy Co Ltd Competitors by Total Assets
Key competitors of Shanghai No1 Pharmacy Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Shanghai No1 Pharmacy Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Shanghai No1 Pharmacy Co Ltd generates 0.97x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Shanghai No1 Pharmacy Co Ltd generates $8.24 in net profit.
Shanghai No1 Pharmacy Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.59 | 1.68 | 1.81 |
| Quick Ratio | 1.00 | 1.18 | 1.42 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥427.32 Million | CN¥ 452.42 Million | CN¥ 473.43 Million |
Shanghai No1 Pharmacy Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanghai No1 Pharmacy Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.45 |
| Latest Market Cap to Assets Ratio | 0.09 |
| Asset Growth Rate (YoY) | 6.3% |
| Total Assets | CN¥1.98 Billion |
| Market Capitalization | $180.65 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai No1 Pharmacy Co Ltd's assets below their book value (0.09 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai No1 Pharmacy Co Ltd's assets grew by 6.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai No1 Pharmacy Co Ltd (1994–2024)
The table below shows the annual total assets of Shanghai No1 Pharmacy Co Ltd from 1994 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.98 Billion | +6.27% |
| 2023-12-31 | CN¥1.86 Billion | -8.63% |
| 2022-12-31 | CN¥2.04 Billion | +52.80% |
| 2021-12-31 | CN¥1.33 Billion | -4.43% |
| 2020-12-31 | CN¥1.40 Billion | +14.77% |
| 2019-12-31 | CN¥1.22 Billion | +12.70% |
| 2018-12-31 | CN¥1.08 Billion | -4.97% |
| 2017-12-31 | CN¥1.14 Billion | -4.16% |
| 2016-12-31 | CN¥1.19 Billion | -3.65% |
| 2015-12-31 | CN¥1.23 Billion | +13.80% |
| 2014-12-31 | CN¥1.08 Billion | +17.99% |
| 2013-12-31 | CN¥916.16 Million | +2.68% |
| 2012-12-31 | CN¥892.27 Million | +12.35% |
| 2011-12-31 | CN¥794.21 Million | +0.76% |
| 2010-12-31 | CN¥788.18 Million | +9.23% |
| 2009-12-31 | CN¥721.57 Million | +22.49% |
| 2008-12-31 | CN¥589.11 Million | -15.43% |
| 2007-12-31 | CN¥696.57 Million | +44.77% |
| 2006-12-31 | CN¥481.15 Million | +40.01% |
| 2005-12-31 | CN¥343.66 Million | -19.89% |
| 2004-12-31 | CN¥429.02 Million | -11.56% |
| 2003-12-31 | CN¥485.08 Million | +1.40% |
| 2002-12-31 | CN¥478.39 Million | -0.91% |
| 2001-12-31 | CN¥482.76 Million | +0.76% |
| 2000-12-31 | CN¥479.14 Million | -35.75% |
| 1999-12-31 | CN¥745.71 Million | -24.43% |
| 1998-12-31 | CN¥986.83 Million | -16.06% |
| 1997-12-31 | CN¥1.18 Billion | -15.09% |
| 1996-12-31 | CN¥1.38 Billion | +13.75% |
| 1995-12-31 | CN¥1.22 Billion | +68.16% |
| 1994-12-31 | CN¥723.83 Million | -- |